Skip to main content
Smart Investors Daily
Humana Inc. logo

NYSE · HUM

Humana Inc.

Healthcare · Medical - Healthcare Plans

$417.56

Down-$2.18 (-0.52%)

Updated Oct 30, 2026, 9:52 PM

SID Score

7.3/10

Composite research score

Smart Money

58/100

Neutral

Market cap
32B
P/E ratio
24.85
Dividend yield
1.06%
52-week range
$163.11 – $456.50
Volume
1.02M
Avg. volume
1.8M

Price performance · HUM

HUM price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

HUM closed at $417.56 after 21 trading sessions, up 9.98% for the selected period.

Last close
$417.56
Period change
+9.98%
Period low
$379.68
Period high
$433.50
Daily close
View OHLC price history
HUM OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 29, 2026$416.11$418.56$408.79$417.561.02M
Oct 28, 2026$416.00$421.95$410.95$411.871.05M
Oct 27, 2026$416.66$420.025$411.58$414.85697.31K
Oct 26, 2026$426.27$430.15$415.26$417.221.3M
Oct 23, 2026$420.60$425.925$417.00$422.071.2M
Oct 22, 2026$423.16$428.305$417.49$420.971.81M
Oct 21, 2026$431.52$434.125$423.85$425.421.48M
Oct 20, 2026$416.50$430.32$416.50$427.382.01M
Oct 19, 2026$413.01$423.12$407.50$414.981.38M
Oct 16, 2026$432.40$432.40$411.77$413.161.41M
Oct 15, 2026$430.00$437.705$429.44$432.201.04M
Oct 14, 2026$421.61$432.15$421.61$427.401.11M
Oct 13, 2026$439.02$442.99$410.505$420.381.9M
Oct 12, 2026$434.57$438.39$423.15$433.501.7M
Oct 9, 2026$450.49$456.50$428.4461$431.874.99M
Oct 8, 2026$396.03$399.19$375.86$387.122.68M
Oct 7, 2026$410.00$410.01$394.81$396.511.83M
Oct 6, 2026$405.02$408.04$396.04$404.271.98M
Oct 5, 2026$389.98$409.17$385.20$404.071.52M
Oct 2, 2026$378.54$390.00$378.50$388.36765.06K
Oct 1, 2026$380.00$386.86$376.225$379.68891.93K

Latest HUM news

The latest Smart Investors Daily articles mentioning HUM.

HUM research

Overview

Company profile and research snapshot.

Company profile

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$293.17
Implied upside
—
Analysts
—
HUM recent ratings
DateFirmRatingTarget
Oct 13, 2026MizuhoOutperform—
Oct 12, 2026Raymond JamesOutperform—
Oct 12, 2026UBSNeutral—
Oct 12, 2026OppenheimerOutperform—
Oct 12, 2026Truist SecuritiesHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 23, 2026

Humana (OM:HUM) Q3 Results Confront A Persistent Margin Squeeze

Humana just posted its Q3 2026 scorecard and the headline is simple. Profit swung back to a solid quarter with basic earnings per share of 2.59 SEK on revenue of 2,595 million SEK. The share price, sitting at SEK70.40 into the release with a 7‑day return effectively flat, reflected a market still unsure about the story. The real tension is psychological. Traders are reacting to a healthcare operator that now earns a trailing P/E of 18.8x while carrying a thin 1.8% net margin and a history of...

Yahoo · Oct 21, 2026

How Clinic JV Funding At Humana (HUM) Has Changed Its Investment Story

Humana announced a joint venture with HPS Investment Partners, part of BlackRock, to manage nearly 150 CenterWell Senior Primary Care clinics, with BlackRock acquiring WCAS’s equity stake valued at about US$2.8b and Humana expecting reduced balance sheet liabilities. The structure keeps CenterWell running the clinics while bringing in fresh capital for new locations and acquisitions. This directly affects Humana’s capital intensity, funding sources, and long term optionality to buy back the...

Yahoo · Oct 21, 2026

Humana (HUM) Recasts CenterWell Clinics With New Joint Venture And Fresh Capital

Humana (NYSE:HUM) has formed a new joint venture with BlackRock's HPS Investment Partners to operate CenterWell senior primary care clinics. The HPS Investment Partners vehicle becomes the new majority owner of the CenterWell clinics platform, replacing Humana's prior partner Welsh, Carson, Anderson & Stowe. The refreshed structure is intended to fund CenterWell clinic expansions and acquisitions while removing earlier put arrangements that sat on Humana's balance sheet. Humana's new...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.